Cadila Pharmaceuticals Limited

Cadila Pharmaceuticals Limited (India) holds 32 active US FDA Type II Drug Master Files and 26 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 4 FDA-registered manufacturing sites. 3 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Cadila Pharmaceuticals Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/cadila-pharmaceuticals-limited

Overview

Cadila Pharmaceuticals Limited is one of the largest privately held pharmaceutical companies in India, committed to the development and commercialization of innovative therapeutic solutions. With a wide-ranging portfolio that spans numerous therapeutic areas, Cadila is dedicated to improving patient outcomes globally.

Core services & business areas

Pharmaceutical ManufacturingResearch and DevelopmentRegulatory AffairsClinical TrialsDistribution

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Cadila Pharmaceuticals Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Cadila Pharmaceuticals Limited holds 32 active (58 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • GEMFIBROZIL USPActive2020-07-10
  • HYDRALAZINE HYDROCHLORIDE USPActive2020-07-03
  • VENLAFAXINE HYDROCHLORIDE USP (PROCESS-2)Active2015-09-23
  • ARIPIPRAZOLE USPActive2015-09-11
  • BUPROPION HYDROCHLORIDE USPActive2014-12-31
  • CARVEDILOL USPActive2014-04-18
  • ATORVASTATIN CALCIUM USP FORM-IActive2014-04-16
  • PHTHALOYL AMLODIPINEActive2014-01-31
  • NATEGLINIDE FORM H USPActive2013-06-21
  • RALOXIFENE HYDROCHLORIDE USPActive2013-05-06
  • BOSENTAN MONOHYDRATEActive2013-03-05
  • VALSARTAN USP (PROCESS 2)Active2012-07-07
  • PALIPERIDONE USPActive2010-11-29
  • OLMESARTAN MEDOXOMIL USPActive2009-08-26
  • ATOMOXETINE HYDROCHLORIDE USPActive2009-08-11
  • O-DESMETHYL VENLAFAXINE SUCCINATEActive2009-01-22
  • ESCITALOPRAM OXALATE USPActive2009-01-06
  • OLANZAPINE FORM-I USPActive2008-12-09
  • SILDENAFIL CITRATE USPActive2007-12-13
  • DESLORATADINEActive2007-12-11
  • NEBIVOLOL HYDROCHLORIDEActive2007-12-08
  • ALEDRONATE SODIUM USPActive2007-07-11
  • CHLORHEXIDINE GLUCONATE SOLUTION USPActive2006-06-26
  • CELECOXIB USPActive2006-01-19
  • CHLORHEXIDINE BASEActive2006-01-03
  • VENLAFAXINE HYDROCHLORIDE USPActive2005-09-16
  • LORATADINE USP POWDERActive2004-07-10
  • GLYBURIDE USPActive2004-01-14
  • AMLODIPINE BESYLATE USPActive2003-09-13
  • ONDANSETRON HYDROCHLORIDE USPActive2003-09-04
  • FLUOXETINE HYDROCHLORIDE USPActive1999-06-29
  • ETHAMBUTOL HYDROCHLORIDE USPActive1994-10-31
  • RUPATADINE FUMARATEInactive2012-09-27
  • DULOXETINE HYDROCHLORIDEInactive2009-06-05
  • TELMISARTANInactive2009-01-21
  • VALSARTANInactive2008-11-14
  • NATEGLINIDE FORM BInactive2008-09-09
  • ATORVASTATIN CALCIUMInactive2008-08-26
  • PHENYLEPHRINE TANNATEInactive2008-06-07
  • IRBESARTAN (POLYMORPHIC FORM-A)Inactive2007-12-31
  • Carbetapentane TannateInactive2007-11-29
  • ITOPRIDE HYDROCHLORIDEInactive2007-11-28
  • RABEPRAZOLE SODIUMInactive2007-10-30
  • OndansetronInactive2007-10-29
  • DIPHENHYDRAMINE TANNATEInactive2007-08-23
  • PSEUDOEPHEDRINE TANNATEInactive2007-08-06
  • LOSARTAN POTASSIUM USPInactive2007-05-03
  • ARIPIPRAZOLEInactive2007-04-12
  • ROPINIROLE HYDROCHLORIDEInactive2006-08-18
  • MELOXICAMInactive2006-01-19

Showing the 50 most relevant of 58 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (4)

Physical sites registered with the US FDA and resolved to Cadila Pharmaceuticals Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

3 FDA enforcement records linked to this company.

  • 4832018-05-03

    Testing and release for distribution

  • recall — Class II2016-12-07

    Microbial Contamination of Non-Sterile Product

  • warning_letter2014-10-15

    FDA Warning Letter (drug product)

For suppliers

Is this Cadila Pharmaceuticals Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.